ClinicalTrials.govpublic full text
Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)
varicella, measles, mumps, rubella, diphtheria, tetanus, pertussis, poliomyelitis, hepatitis b, haemophilus infections, mumps and rubella, haemophilus influenzae type b (infanrix® hexa)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 865939
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.